Advanced Oncotherapy Share Discussion Threads

[scantrader] 28/2/2017 13:44

Yep - I tried Cloudtag and couldn't. Sometimes they make you close your shorts too - damned annoying.

[1savvyinvestor] 28/2/2017 13:28

Maybe I got in just in time! Was like ctag . Tried to increase a short there two weeks ago and couldn't

[scantrader] 28/2/2017 12:50

I just checked the IG pdf and it has an x rather than tick for ability to short AVO

[scantrader] 28/2/2017 12:43

Interesting - thanks , not checked spreadex but last time I looked you couldn't open NEW short positions on any of the spread betters I'm familiar with.

[1savvyinvestor] 28/2/2017 12:30

I'm short with Spreadex

[scantrader] 28/2/2017 12:16

As far as I'm aware there's nowhere you can go short on it now. I closed about three quarters of mine some months ago, prematurely with hindsight.

[barnetpeter] 28/2/2017 10:33

This is an ideal short.....these are death spirals. They exercise, dump the stock, force the price down, exercise at a lower price and so on.

[igbertsponk] 28/2/2017 09:57

Yes smithless - get the turkeys to vote for Christmas!

[smithless] 28/2/2017 09:51

Igbert -call another egm, if its not already on the current egm list and take it down to 2.5p - problem solved

[vatnabrekk] 28/2/2017 08:28

These sorts of finance deals are destructive.

[igbertsponk] 28/2/2017 08:25

What happens when they (pretty soon I guess) try to issue 25p nominal value shares for less than 25p cash as the conversions continue ?
Helter skelter now - anyone still in is very brave.

[sweet karolina] 28/2/2017 08:13

First conversion of many and the share price is already crumbling. There just is not the buying power here to soak up all the new shares as they get issued.

[scantrader] 28/2/2017 00:48

For anyone who missed it on this board Tom W's site posted a damning downgrade
note from AVO's house broker earlier today. (And for inexperienced investors a hold rec from a house broker should actually be taken as a sell rec.)

I see from the other board that even Meldrew (daijavu over here)has sold up now!

[loglorry1] 26/2/2017 21:08

Having had a quick look at this today it looks like a frighteningly expensive business to get going. They seem to have made some progress but goodness knows how much money they'll need before they don't need further funding.

[vatnabrekk] 26/2/2017 15:36

CERN are the ones with the technical know-how. I don't know what financial arrangement there is between them and AVO.

[loglorry1] 26/2/2017 11:47

Thanks Vanabrekk. Is the deal with CERN publicly disclosed? Are they suppliers of the components for cash or license fee or have they supplied hardware / expertise for an equity stake which they have retained and hope to profit from it's future success? In short have CERN risked any cash?

[vatnabrekk] 26/2/2017 10:53

As far as I'm aware there isn't any third party verification at the moment because they are still working on the prototype. But they are supported by CERN so that must be some comfort. So at the moment we only have what AVO tell us on their web site. But if what they say is true, and there is no reason to suspect otherwise, then it will truly be ground breaking technology: smaller, safer, cheaper than any of the existing equipment.

[loglorry1] 26/2/2017 10:22

Can anyone tell me what the bull case is for the tech here? Why is it better / cheaper than existing tech? Has it been clinically evaluated to show better positive outcomes? Have any large health care organisations bought it or similar tech? I'm not really talking about what the compamy says but more like 3rd party validation. I'm aware of the Chinese deal but that could well have never had any substance the way it was structured.

I'm new to the story but do recall some poor lad with a brain tumour went to E Europe for this treatment b/c it wasn't available in the UK.

[vatnabrekk] 25/2/2017 18:17

Whatever anyone may think of TW, I agree with him that AVO have been shafted by Bracknor. TW explains how they can sidestep the requirement not to short sell ahead of any conversion notice, because they can of course sell any shares that they hold, driving the share price down so that they get a better deal on the conversion price.

It seems to me that AVO have had the wool well and truly pulled over their eyes.

But then, did they really have any choice anyway, given the situation that they now find themselves in.

[glibgibon] 24/2/2017 23:38

They had to get financing completed this month or pay back the £11M or whatever it was they have already received from Metric - and not get the rest of the money. I am hoping Metric's money will last until testing is complete, but I am not too keen on the new debt having a minimum requirement followed by an option of much more dilution.

Is the requirement that AVO MUST draw down £13M?
And they have the option of another £13M within 2 years - and if they take the £26M within 2 years, they can have another £26M on the same terms? I note they must take at least 20 days before each £1.3M tranche - I really hope they don't need to spend that much money so quickly.

"The company has the right to refuse up to 2 calls". What does that mean?
The company is AVO and the drawdown is done at their discretion, so what exactly is being refused? I have looked at put and call options, but still not clear as to what is applied here. Is it AVO can twice refuse warrants to be exercised?

I need to clear some time to make sure I get this straight, but any tips most welcome.

[igbertsponk] 24/2/2017 08:18

Drawdown no doubt needed to pay the salaries this month. Shows how desperate AVO were: proof one again that Bracknor were the lender of last resort.

[smithless] 24/2/2017 07:56

On my calculations Bracknor has 2m shares to sell then, based on a conversion price of 65p announced 22 Feb? It states in todays announcement 'Bracknor is prohibited from short selling ahead of any conversion notice, being the notice given to the Company that Bracknor wishes to convert the loan notes into AVO shares' which means Bracknor in future tranches will notify the company, it will sit on the information, Bracknor will forward sell and close off the position. I not sure if I trust a single word the company is making, just like the non dilutive loan which never happened and the Chinese contract that walked away.

[twirl] 23/2/2017 17:42

Harley St was a strategic decision upon which shareholders were not consulted and a mistake which led to the now disastrous Metric deal all built on the sands of testing hope.
Just an example of trying to run before you can walk. On the subject of walking its the near 2 month delay in testing and the faiure to give hope to Sinophi or lenders that testing will conclude anytime soon that has hit the share price and led to this latest dilution bad news.

IMHO